- Home
- LFMD vs ESPR Comparison
LFMD vs ESPR Comparison
Compare LFMD & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LFMD
- ESPR
- Stock Information
- Founded
- LFMD 1994
- ESPR 2008
- Country
- LFMD United States
- ESPR United States
- Employees
- LFMD N/A
- ESPR N/A
- Industry
- LFMD Medical/Nursing Services
- ESPR Biotechnology: Pharmaceutical Preparations
- Sector
- LFMD Health Care
- ESPR Health Care
- Exchange
- LFMD Nasdaq
- ESPR Nasdaq
- Market Cap
- LFMD 306.7M
- ESPR 305.0M
- IPO Year
- LFMD N/A
- ESPR 2013
- Fundamental
- Price
- LFMD $5.94
- ESPR $1.50
- Analyst Decision
- LFMD Strong Buy
- ESPR Buy
- Analyst Count
- LFMD 7
- ESPR 7
- Target Price
- LFMD $11.57
- ESPR $6.36
- AVG Volume (30 Days)
- LFMD 2.0M
- ESPR 3.9M
- Earning Date
- LFMD 03-10-2025
- ESPR 03-04-2025
- Dividend Yield
- LFMD N/A
- ESPR N/A
- EPS Growth
- LFMD N/A
- ESPR N/A
- EPS
- LFMD N/A
- ESPR N/A
- Revenue
- LFMD $212,453,838.00
- ESPR $332,314,000.00
- Revenue This Year
- LFMD $23.50
- ESPR $5.51
- Revenue Next Year
- LFMD $17.20
- ESPR $1.42
- P/E Ratio
- LFMD N/A
- ESPR N/A
- Revenue Growth
- LFMD 39.27
- ESPR 185.66
- 52 Week Low
- LFMD $3.99
- ESPR $1.47
- 52 Week High
- LFMD $12.88
- ESPR $3.94
- Technical
- Relative Strength Index (RSI)
- LFMD 53.71
- ESPR 34.95
- Support Level
- LFMD $4.13
- ESPR $1.47
- Resistance Level
- LFMD $6.50
- ESPR $1.61
- Average True Range (ATR)
- LFMD 0.54
- ESPR 0.13
- MACD
- LFMD 0.06
- ESPR -0.01
- Stochastic Oscillator
- LFMD 76.37
- ESPR 7.69
About LFMD LifeMD Inc.
LifeMD Inc is a direct-to-patient telehealth company that provides a smarter, cost-effective, and more convenient way of accessing comprehensive, virtual healthcare. Its telehealth platform seamlessly integrates a clinician-centric electronic medical record (EMR) system, proprietary algorithms for case-load balancing and scheduling, customer relationship management functionality, remote and in-home lab testing, and digital prescription capabilities, patient-provider audio/video interfacing, cloud pharmacy fulfillment, and more. In addition to telehealth offerings, the company sells nutritional supplements and other over-the-counter products. The company has two operating segments: Telehealth and WorkSimpli. The company generates the majority of its revenue from the Telehealth segment.
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The Company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.